Immunize.org has been refreshed! Take a tour.

Pneumococcal

Clinical Resources

Materials for Providers

Alphabetical by Title

Standing Orders for Administering Pneumococcal Conjugate Vaccine to Children

Eligible healthcare professionals may vaccinate children who meet any of the criteria on this form

View PDF

Standing Orders for Administering Pneumococcal Polysaccharide Vaccine (PPSV) to Children and Teens

Eligible healthcare professionals may vaccinate children and teens who meet any of the criteria on this form

View PDF

Standing Orders for Administering Pneumococcal Vaccines (PCV15, PCV20, and PPSV23) to Adults

Eligible healthcare professionals may vaccinate adults who meet any of the criteria on this form

View PDF

Materials for Vaccine Recipients

Alphabetical by Title

Pneumococcus: Questions and Answers

Information about the disease and vaccines for patients and parents

View PDF

View all Clinical Resources

Ask the Experts

What vaccines are indicated for someone who does not have a functioning spleen?

Read more

Do any of the bacterial vaccines that are recommended for people with functional or anatomic asplenia need to be given before splenectomy? Do the doses count if they are given during the 2 weeks prior to surgery?

Read more

My 36-year-old patient was diagnosed with idiopathic thrombocytopenic purpura and had a splenectomy three weeks ago. Prior to the splenectomy, he had one dose each of Hib, MenB, PCV13, MenACWY (Menveo), and PPSV23 (separated from the PCV13 by 9 weeks). What vaccines are recommended now?

Read more

Do any of the bacterial vaccines that are recommended for people with functional or anatomic asplenia need to be given before splenectomy? Do the doses count if they are given during the 2 weeks prior to surgery?

Read more

CDC · FDA · State

ACIP Recommendations

Current Recommendations

ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children ― United States, 2023
MMWR. 2023 / 72(39);1072
Read at CDC.gov
View PDF
Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023.
MMWR. 2023 / 72(RR-3);1–39
Read at CDC.gov
View PDF
Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices—United States, 2022
MMWR, September 16, 2022, 71(37);1174–1181
Read at CDC.gov
View PDF
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR, January 28, 2022, 71 (4); 109-117
Read at CDC.gov
View PDF
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged 65 Years and older: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR, November 22, 2019; 68(46):1069–1075
Read at CDC.gov
View PDF
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, September 4, 2015; 64(34):944-947
Read at CDC.gov
View PDF
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged >65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, September 19, 2014; 63(37):822-825
Read at CDC.gov
View PDF
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, June 28, 2013; 62(25):521-524
Read at CDC.gov
View PDF
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, October 12, 2012; 61(40):816-9
Read at CDC.gov
View PDF
Prevention of Pneumococcal Disease Among Infants and Children–Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
MMWR, December 10, 2010; 59(RR11):1-18
Read at CDC.gov
View PDF
Updated ACIP Recommendations: Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23)
MMWR, September 3, 2010; 59(34):1102-6
Read at CDC.gov
View PDF

Additional Federal Resources

Vaccine Information Statements

Multi-vaccine VIS
Updated: July 24, 2023
View PDF
PCV (Pneumococcal Conjugate) VIS
Updated: May 12, 2023
View PDF
PPSV (Pneumococcal Polysaccharide) VIS
Updated: October 30, 2019
View PDF

FDA Package Inserts & EUAs

Pneumococcal (PCV): Prevnar 20 Package Insert
Pfizer
Download
Pneumococcal (PCV): Vaxneuvance (PCV15) Package Insert
Merck & Co, Inc.
Download
Pneumococcal (PCV): Prevnar 13 Package Insert
Pfizer
Download
Pneumococcal (PPSV): Pneumovax 23 Package Insert
Merck & Co., Inc.
Download

State Policies

View State Pneumococcal Conjugate Vaccine (PCV) Requirements for Childcare
U.S. map of PCV requirements
View PDF

More from Immunize.org

Unprotected People Stories

Photos & Videos

Image Library
Webinars
Videos

This page was updated on .

Our Affiliated Sites

For the Public: VaccineInformation.org
For Coalitions: ImmunizationCoalitions.org
65+ Flu Defense
Protect vulnerable, older adult patients from influenza.
Give2MenACWY.org
Improve protection from meningococcal serogroups ACWY.
Mass Vaccination Resources
Access guidance documents, toolkits, and helpful resources.
NAIIS
Home of the National Adult and Influenza Immunization Summit.